Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytes
2023 · Nature Biomedical Engineering · 124 citations
https://doi.org/10.1038/s41551-023-01032-2
V
Vincent Allain
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
49
Papers
831
Citations
13
h-index
16
i10-index
Vincent Allain is an academic researcher from Gladstone Institutes. The author has contributed to research in topics: CAR-T cell therapy research & Immune Cell Function and Interaction & T-cell and B-cell Immunology. The author has an h-index of 13, co-authored 42 publications.
ORCID: 0000-0002-1068-7892Papers by this author
worksAn evolved AAV variant enables efficient genetic engineering of murine T cells
2023 · Cell · 82 citations
https://doi.org/10.1016/j.cell.2022.12.022
Base-editing mutagenesis maps alleles to tune human T cell functions
2023 · Nature · 81 citations
https://doi.org/10.1038/s41586-023-06835-6
Effect of early granulocyte-colony-stimulating factor administration in the prevention of febrile neutropenia and impact on toxicity and efficacy of anti-CD19 CAR-T in patients with relapsed/refractory B-cell lymphoma
2022 · Bone Marrow Transplantation · 66 citations
https://doi.org/10.1038/s41409-021-01526-0
A major role for CD4+ T cells in driving cytokine release syndrome during CAR T cell therapy
2023 · Cell Reports Medicine · 51 citations
https://doi.org/10.1016/j.xcrm.2023.101161
Droplet digital PCR allows vector copy number assessment and monitoring of experimental CAR T cells in murine xenograft models or approved CD19 CAR T cell-treated patients
2021 · Journal of Translational Medicine · 31 citations
https://doi.org/10.1186/s12967-021-02925-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat